26 Publications (Page 1 of 2)
2017
Response.
Goddard, Andrew
Clinical medicine (London, England), vol. 17, (no. 6), pp. 588, December 2017. | Journal Article
2010
A key role for orexin in panic anxiety
Johnson, Philip L⋅Johnson, Philip L⋅Truitt, Bill⋅Truitt, William⋅Fitz, Stephanie D⋅Fitz, Stephanie D⋅Minick, Pamela E⋅Minick, Pamela E⋅Dietrich, Amy⋅Dietrich, Amy⋅Sanghani, Sonal⋅Sanghani, Sonal⋅Träskman Bendz, Lil⋅Träskman-bendz, Lil⋅Goddard, Andrew W⋅Goddard, Andrew W⋅Brundin, Lena⋅Brundin, Lena⋅Shekhar, Anantha and Shekhar, Anantha
Nature Medicine, vol. 16, (no. 1), pp. 111-5, Jan 2010. | Journal Article
 
Current perspectives of the roles of the central norepinephrine system in anxiety and depression
Goddard, Andrew W⋅Goddard, Andrew W⋅Ball, Susan G⋅Ball, Susan G⋅Martinez, James⋅Martinez, James⋅Robinson, Michael J⋅Robinson, Michael J⋅Yang, Charles R⋅Yang, Charles R⋅Russell, James M⋅Russell, James M⋅Ph D, Anantha S and Shekhar, Anantha
Depression and Anxiety (Hoboken), vol. 27, (no. 4), pp. 339-350, 2010. | Journal Article
 
Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder
Coric, Vladimir⋅Coric, Vladimir⋅Coric, V.⋅Feldman, H.H.⋅Feldman, Howard H⋅Feldman, Howard H⋅Oren, Dan A⋅Oren, Dan A⋅Oren, D.A.⋅Shekhar, Anantha⋅Ph D, Anantha S⋅Shekhar, A.⋅Pultz, Joseph⋅Pultz, Joseph⋅Pultz, J.⋅Dockens, Randy C⋅Dockens, R.C.⋅Dockens, Randy C⋅Wu, Xiaoling⋅Wu, Xiaoling⋅Wu, X.⋅Gentile, Kimberly A⋅Gentile, Kimberly A⋅Gentile, K.A.⋅Huang, Shu-Pang⋅Huang, Shu‐Pang⋅Huang, S.-P.⋅Ph, D.⋅Emison, Eileen⋅Emison, E.⋅Delmonte, Terrye⋅Emison, Eileen⋅Delmonte, T.⋅D’Souza, B.B.⋅D'Souza, Bernadette B⋅Delmonte, Terrye⋅Zimbroff, Daniel L⋅D'Souza, Bernadette B⋅Zimbroff, D.L.⋅Zimbroff, Daniel L⋅Grebb, Jack A⋅Grebb, J.A.⋅Goddard, Andrew W⋅Grebb, Jack A⋅Goddard, A.W.⋅Stock, E.G.⋅Goddard, Andrew W⋅Stock, Elyse G and Stock, Elyse G
Depression and Anxiety (Hoboken), vol. 27, (no. 5), pp. 417-425, 2010. | Journal Article
2008
Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder.
Goddard, Andrew W⋅Shekhar, Anantha⋅Whiteman, Aaron F and Mc Dougle, Christopher J
Drug discovery today, vol. 13, (no. 7-8), pp. 325-32, 2008/Apr. | Journal Article
2006
Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus.
Kaabi, Belhassen⋅Gelernter, Joel⋅Woods, Scott W⋅Goddard, Andrew W⋅Page, Grier P and Elston, Robert C
American journal of human genetics, vol. 78, (no. 4), pp. 543-53, 2006/Apr. | Journal Article
2005
Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
Ball, Susan G⋅Kuhn, Angela⋅Wall, Delynda⋅Shekhar, Anantha and Goddard, Andrew W
The Journal of clinical psychiatry, vol. 66, (no. 1), pp. 94-9, 2005/Jan. | Journal Article
2004
Family Psychopathology and Magnitude of Reductions in Occipital Cortex GABA Levels in Panic Disorder
Goddard, Andrew W⋅Mason, Graeme F⋅Rothman, Douglas⋅Behar, Kevin L⋅Petroff, Ognen A and Krystal, John H
Neuropsychopharmacology, vol. 29, (no. 3), pp. 639-640, Mar 2004. | Journal Article
 
Impaired GABA Neuronal Response to Acute Benzodiazepine Administration in Panic Disorder
Goddard, Andrew W⋅Mason, Graeme Finlay⋅Appel, Michael⋅Rothman, Douglas⋅Gueorguieva, Ralitza V⋅Behar, Kevin and Krystal, John H
American Journal of Psychiatry, vol. 161, (no. 12), pp. 2186-2193, 2004. | Journal Article
2002
Evaluating and treating anxiety disorders in medical settings.
Ball, S⋅Goddard, Andrew W and Shekhar, Anantha
Journal of postgraduate medicine, vol. 48, (no. 4), pp. 317-21, 2002 Oct-Dec. | Journal Article
2001
Early coadministration of clonazepam with sertraline for panic disorder.
Goddard, Andrew W⋅Brouette, T⋅Almai, A⋅Jetty, P⋅Woods, Scott W and Charney, Dennis S
Archives of general psychiatry, vol. 58, (no. 7), pp. 681-6, 2001/Jul. | Journal Article
 
Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients.
Asnis, Gregory M⋅Hameedi, F A⋅Goddard, Andrew W⋅Potkin, S G⋅Black, D⋅Jameel, M⋅Desagani, K and Woods, Scott W
Psychiatry research, vol. 103, (no. 1), pp. 1-14, 2001/Aug/5. | Journal Article
 
Linkage genome scan for loci predisposing to panic disorder or agoraphobia.
Gelernter, Joel⋅Bonvicini, K⋅Page, Grier P⋅Woods, S W⋅Goddard, Andrew W⋅Kruger, S⋅Pauls, D L and Goodson, S
American journal of medical genetics. , vol. 105, (no. 6), pp. 548-57, 2001/Aug/8. | Journal Article
 
Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy.
Goddard, Andrew W⋅Mason, Graeme F⋅Almai, A⋅Rothman, D L⋅Behar, Kevin L⋅Petroff, Ognen A⋅Charney, D S and Krystal, John H
Archives of general psychiatry, vol. 58, (no. 6), pp. 556-61, 2001/Jun. | Journal Article
 
Reductions in occipital cortex GABA levels in panic disorder detected with H-magnetic resonance spectroscopy
Goddard, Andrew W⋅Mason, Graeme F⋅Almai, Ahmad⋅Rothman, Douglas L and al, et
Archives of General Psychiatry, vol. 58, (no. 6), pp. 556-61, Jun 2001. | Journal Article
2000
Temporal lobe volume in panic disorder--a quantitative magnetic resonance imaging study.
Vythilingam, M⋅Anderson, E R⋅Goddard, Andrew W⋅Woods, Scott W⋅Staib, Lawrence H⋅Charney, Dennis S and Bremner, James D
Psychiatry research, vol. 99, (no. 2), pp. 75-82, 2000/Aug/28. | Journal Article
1999
Effects of the CCK(B) antagonist CI-988 on responses to mCPP in generalized anxiety disorder.
Goddard, Andrew W⋅Woods, S W⋅Money, R⋅Pande, A C⋅Charney, D S⋅Goodman, W K⋅Heninger, G R and Price, L H
Psychiatry Research, vol. 85, (no. 3), pp. 225-40, 1999/Mar/22. | Journal Article
1998
Efficient allocation of patients to treatment cells in clinical trials with more than two treatment conditions.
Woods, Scott W⋅Sholomskas, D E⋅Shear, M. K⋅Gorman, Jack M⋅Barlow, David H⋅Goddard, Andrew W and Cohen, J
The American journal of psychiatry, vol. 155, (no. 10), pp. 1446-8, 1998/Oct. | Journal Article
1997
Toward an integrated neurobiology of panic disorder.
Goddard, Andrew W and Charney, Dennis S
The Journal of clinical psychiatry, vol. 58 Suppl 2, pp. 4-11; discussion 11-2, 1997. | Journal Article
 
Toward an integrated neurobiology of panic disorder / Discussion
Goddard, Andrew W⋅Charney, Dennis S⋅Rosenbaum, Jerrold F⋅Ballenger, James C and al, et
The Journal of Clinical Psychiatry, vol. 58, pp. 4, 1997. | Journal Article
1996
Plasma levels of gamma-aminobutyric acid and panic disorder.
Goddard, Andrew W⋅Narayan, M⋅Woods, S W⋅Germine, M⋅Kramer, G L⋅Davis, L L and Petty, F
Psychiatry Research, vol. 63, (no. 2-3), pp. 223-5, 1996/Jul/31. | Journal Article
1995
Effects of tryptophan depletion on responses to yohimbine in healthy human subjects.
Goddard, Andrew W⋅Charney, D S⋅Germine, M⋅Woods, S W⋅Heninger, G R⋅Krystal, J H⋅Goodman, W K and Price, L H
Biological Psychiatry, vol. 38, (no. 2), pp. 74-85, 1995/Jul/15. | Journal Article
1994
Effects of tryptophan depletion in panic disorder.
Goddard, Andrew W⋅Sholomskas, D E⋅Walton, K E⋅Augeri, F M⋅Charney, Dennis S⋅Heninger, George R⋅Goodman, Wayne K and Price, Lawrence H
Biological psychiatry, vol. 36, (no. 11), pp. 775-7, 1994/Dec/1. | Journal Article
 
Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: influence of reduction in intravenous dosage.
Germine, M⋅Goddard, Andrew W⋅Sholomskas, D E⋅Woods, Scott W⋅Charney, D S and Heninger, George R
Psychiatry research, vol. 54, (no. 2), pp. 115-33, 1994/Nov. | Journal Article
1993
Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.
Goddard, Andrew W⋅Woods, Scott W⋅Sholomskas, D E⋅Goodman, Wayne K⋅Charney, D S and Heninger, George R
Psychiatry research, vol. 48, (no. 2), pp. 119-33, 1993/Aug. | Journal Article